Evidence map›Paper›PMID 34160622›Full record

ArticleTranslational behavioral medicine2021

Cost, reach, and representativeness of recruitment efforts for an online skin cancer risk reduction intervention trial for young adults.

Carolyn J Heckman, Mary Riley, Olga Khavjou, Pamela Ohman-Strickland, Sharon L Manne, Amy L Yaroch, Trishnee Bhurosy, Elliot J Coups, Karen Glanz

Registry-linked trialAbstract read
In one paragraph

Article in Translational behavioral medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03313492 (Modifying Young Adult Skin Cancer Risk and Protective Behaviors), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03313492 nacompletednot on this map

Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2): A Hybrid Type 2 Dissemination/Effectiveness Trial

TypeinterventionalSponsorRutgers, The State University of New JerseyRan2018 to 2020Enrolled1,746ConditionsMelanoma and Other Malignant Neoplasms of SkinArmsUV4.me2, UV4.me, E-Pamphlet
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Digital Skin Cancer Risk Reduction Interventions for Young Adults: Findings from a Hybrid Type-II Effectiveness-Implementation Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carolyn J HeckmanRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.ORCID 0000-0003-1016-3965
Mary RileyRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Olga KhavjouRTI International, Research Triangle Park, NC, USA.
Pamela Ohman-StricklandRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Sharon L ManneRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Amy L YarochGretchen Swanson Center for Nutrition, Omaha, NE, USA.
Trishnee BhurosyRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Elliot J CoupsMedical Data Analytics, Parsippany, NJ, USA.
Karen GlanzDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2):A Hybrid Type 2 Dissemination/Effectiveness TrialR01CA204271 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI HECKMAN, CAROLYN · 2017 to 2021
$2.9M
NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA204271NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

Despite its increasing use, few studies have reported on demographic representativeness and costs of research recruitment via social media. It was hypothesized that cost, reach, enrollment, and demographic representativeness would differ by social media recruitment approach. Participants were 18-25 year-olds at moderate to high risk of skin cancer based on phenotypic and behavioral characteristics. Paid Instagram, Facebook, and Twitter ads, unpaid social media posts by study staff, and unpaid referrals were used to recruit participants. Demographic and other characteristics of the sample were compared with the 2015 National Health Interview Survey (NHIS) sample. Analyses demonstrated significant differences among recruitment approaches regarding cost efficiency, study participation, and representativeness. Costs were compared across 4,274 individuals who completed eligibility screeners over a 7-month period from: Instagram, 44.6% (of the sample) = 1,907, $9 (per individual screened); Facebook, 31.5% = 1,345, $8; Twitter, 1% = 42, $178; unpaid posts by study staff, 10.6% and referred, 6.5%, $1. The lowest rates of study enrollment among individuals screened was for Twitter. Most demographic and skin cancer risk factors of study participants differed from those of the 2015 NHIS sample and across social media recruitment approaches. Considering recruitment costs and number of participants enrolled, Facebook and Instagram appeared to be the most useful approaches for recruiting 18-25 year-olds. Findings suggest that project budget, target population and representativeness, and participation goals should inform selection and/or combination of existing and emerging online recruitment approaches.

Indexed as

Internet-Based InterventionSkin NeoplasmsSocial MediaAdolescentAdultClinical Trials as TopicHumansPatient SelectionRisk Reduction BehaviorSurveys and QuestionnairesYoung AdultCostRecruitmentSkin cancer preventionSocial media

Identifiers

PMID34160622
PMCPMC8541696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.